Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma

Pharmaceuticals - Switzerland
doi 10.3390/ph8010001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG